1. (1) A pharmacist or pharmacy intern who will administer a prescription drug or device shall first complete the following appropriate training:

   1. (a) current Basic Life Support (BLS) certification;
   2. (b) for injectable drugs, didactic and practical training for administering injectable drugs;
   3. (c) topics related to the specific prescription drug or device that will be administered;
   4. (d) if administering vaccines, current guidelines from the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC); and
   5. (e) the management of an anaphylactic reaction.
2. (2) A pharmacy technician who will administer a prescription drug or device shall first complete the appropriate training described in Subsections (1)(a), (b), and (e).

3. (3) Sources for the appropriate training include:

   1. (a) ACPE approved programs;
   2. (b) curriculum-based programs from an ACPE accredited college of pharmacy, or an ASHP accredited pharmacy technician program;
   3. (c) state or local health department programs; and
   4. (d) other Board recognized providers.

4. (4) An individual who engages in the administration of prescription drugs or devices shall:

   1. (a) maintain documentation that they obtained their required training; and
   2. (b) for each renewal cycle after their initial training, complete at least two hours of continuing education related to their administration of prescription drugs or devices, under Section R156-17b-309.
5. (5) The "Vaccine Administration Protocol: Standing Order to Administer Immunizations and Emergency Medications", adopted September, 2023, by the Division in collaboration with the Board of Pharmacy and the Utah Medical Licensing Board, as posted on the Division website, is the guideline or standard for pharmacist administration of vaccines and emergency medications, and for pharmacy intern or pharmacy technician administration pursuant to delegation by a pharmacist.

This section establishes training standards under Subsections 58-17b-102(53), (57), and (58), and 58-17b-502(1)(i)(i).

KEY: pharmacists, licensing, pharmacies

Date of Last Change: August 8, 2025

Notice of Continuation: August 5, 2024

Authorizing, and Implemented or Interpreted Law: 63G-3-201; 58-17b-101; 58-17b-601(1); 58-37-1; 58-1-106(1)(a); 58-1-202(1)(a)